cdmo.directory
← Compare landing

Lambda Therapeutic Research vs Viralgen

Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.

CategoryLambda Therapeutic ResearchViralgen
SummaryFull-service global CRO offering Phase I–IV clinical trial management, pharmacovigilance, and bioanalytical labs, plus biologics CDMO services. Has supported 280+ clinical trials across 15+ therapeutic domains.Viralgen is a CDMO specializing exclusively in cGMP AAV gene therapy manufacturing, with the world's largest dedicated AAV production capacity and a 100% success rate for IND/IMPD dossiers across 50+ gene therapy customers.
Services
  • Bioanalysis
  • Clinical Trial Services
  • Phase I Clinical Trials
  • Phase II Clinical Trials
  • Phase III Clinical Trials
  • Phase IV / Post-Marketing
  • Clinical Operations
  • Data Management & eClinical
  • Biostatistics & Statistical Programming
  • Pharmacovigilance & Drug Safety
  • Medical Writing
  • Clinical Imaging Core Lab
  • Regulatory Affairs
  • Regulatory Affairs
  • US FDA Regulatory Strategy
  • EU EMA Regulatory Strategy
  • Analytical Method Development & Validation
Modalities
  • Biologics (Other)
  • Gene Therapy
  • AAV / Viral Vector Platform
Development capabilitiesData not yet provided.Data not yet provided.
Manufacturing capabilitiesData not yet provided.Data not yet provided.
LocationsData not yet provided.
  • Headquarters & Manufacturing, San Sebastián, Basque Country, Spain
CertificationsData not yet provided.
  • EMA · Identifier: AEMPS/EMA certified

Find similar companies

Lambda Therapeutic Research alternatives · Viralgen alternatives

Markdown mirror: /compare/lambda-cro/viralgen.md